Astrazeneca (AZN) Cash from Discontinued Operations (2009 - 2026)

Astrazeneca's Cash from Discontinued Operations history runs 17 years deep, the most recent figure standing at 3359000000.0 for Q1 2026.

• In Q1 2026, Cash from Discontinued Operations fell 9.53% year-over-year to 3359000000.0; the TTM figure through Mar 2026 stood at 14221000000.0 (up 8.66% YoY), while the FY2025 annual figure was 14575000000.0, up 22.88% from the prior year.
• Cash from Discontinued Operations was 3359000000.0 for Q1 2026 at Astrazeneca, up from 2342000000.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 5134000000.0 in Q3 2025 to a low of 1248000000.0 in Q2 2022.
• Historically, Cash from Discontinued Operations has averaged 3009692307.69 across 5 years, with a median of 3133000000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash from Discontinued Operations jumped 111.51% in 2022, then slipped 20.65% in 2024.
• A 5-year view of Cash from Discontinued Operations shows it stood at 1248000000.0 in 2022, then jumped by 37.66% to 1718000000.0 in 2023, then soared by 69.21% to 2907000000.0 in 2024, then declined by 19.44% to 2342000000.0 in 2025, then jumped by 43.42% to 3359000000.0 in 2026.
• The last three Cash from Discontinued Operations figures came in at 3359000000.0 (Q1 2026), 2342000000.0 (Q4 2025), and 5134000000.0 (Q3 2025), per Business Quant data.